Home / Products & Performance / Emerging Cancer HHJ

HealthShares Emerging Cancer ETF [ HHJ ]

HealthShares™ Emerging Cancer ETF (HHJ) is one in a series of HealthShares™ ETFs that are organized Vertically by therapeutic categories in pharmaceuticals, healthcare services, life sciences and biotechnology. HHJ seeks investment results that correspond to the performance before the Fund’s fees and expenses, of HealthShares™ Emerging Cancer Index, an equity index of publicly traded common stocks and ADRs. The Emerging Cancer Index invests in pharmaceutical or biotechnology companies that have been identified as emerging cancer companies. Companies included in the Emerging Cancer Index are engaged in the research, clinical development and/or commercialization of therapeutic agents for the treatment of a wide variety of cancers. Companies in this index generally include those with some level of revenues, or those on the verge of revenues with significant but focused research and development programs. The companies in the universe are selected using a proprietary methodology developed by XShares Group LLC designed to identify companies in a specific healthcare vertical or sub-sector.

HHJ employs a low-cost passive management investment approach designed to track the performance of the HealthShares™ Emerging Cancer Index. HHJ will generally invest at least 90% of its assets in common stocks of companies in the underlying Index.

HHJ intends to pay out any dividends from its net investment income annually, and plans to distribute any net capital gains annually.

XShares Advisors LLC is the investment advisor. Bank of New York acts as custodian and administrator.

Market data
Market Price (10/18/2007)* $21.16
Change $0.13
Volume 800
NAV History     Premium/Discount Chart
NAV as of 10/19/2007 $20.4091
NAV Change $-0.6550
Shares Outstanding 300,200
Total Cash $-10,858.99
Estimated Cash $12,213.23
Bid as of 10/18/2007 $20.91
Mid point as of 10/18/2007 $21.05
Ask as of 10/18/2007 $21.19
Market Price as of 10/19/2007* N/A
Change N/A
Premium/Discount*** N/A
Yield N/A
Expense ratio as of 10/19/2007 0.75%
Inception date 01/23/2007
Ticker symbol HHJ
IOPV** ticker symbol HHJ.IV

* Last Sale.

** Indicative Optimized Portfolio Value.

*** Bid/Ask Midpoint versus NAV.